Aldeyra Therapeutics Shares Are Trading Higher. The Company Announced the Clinical Development Plan Intended to Enable Resubmission of a New Drug Application for Reproxalap in Dry Eye Disease
Aldeyra Therapeutics的股價正在走高。該公司宣佈了旨在重新提交治療乾眼病的Reproxalap新藥申請的臨床開發計劃